Pediatric multiple sclerosis

Ellen Mahar Mowry, Emmanuelle Waubant

Research output: Contribution to journalArticle

Abstract

Multiple sclerosis (MS) onset in childhood occurs in a small proportion of individuals with the disease, although the precise incidence of pediatric MS is unknown. It may be difficult to distinguish the initial attack of pediatric MS from acute disseminated encephalomyelitis, particularly in very young children. Environmental and genetic factors that appear to increase the risk of pediatric MS include prior infection with Epstein-Barr virus, exposure to cigarette smoke, and HLA-DRB1*15 haplotype. Children may have more posterior fossa involvement at onset and a higher relapse rate than adults with MS. Although time to disability may be longer than in adults, pediatric MS is associated with an earlier age of disability. Off-label use of standard disease-modifying therapies for adult MS is common, although data regarding the efficacy and safety for these medications are limited.

Original languageEnglish (US)
Pages (from-to)181-192
Number of pages12
JournalCONTINUUM Lifelong Learning in Neurology
Volume16
Issue number5
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Multiple Sclerosis
Pediatrics
Acute Disseminated Encephalomyelitis
Off-Label Use
HLA-DRB1 Chains
Epstein-Barr Virus Infections
Smoke
Tobacco Products
Haplotypes
Safety
Recurrence
Incidence

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Pediatric multiple sclerosis. / Mowry, Ellen Mahar; Waubant, Emmanuelle.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 16, No. 5, 10.2010, p. 181-192.

Research output: Contribution to journalArticle

Mowry, Ellen Mahar ; Waubant, Emmanuelle. / Pediatric multiple sclerosis. In: CONTINUUM Lifelong Learning in Neurology. 2010 ; Vol. 16, No. 5. pp. 181-192.
@article{363bbd738ba24cffa6b7c41fe37f7c90,
title = "Pediatric multiple sclerosis",
abstract = "Multiple sclerosis (MS) onset in childhood occurs in a small proportion of individuals with the disease, although the precise incidence of pediatric MS is unknown. It may be difficult to distinguish the initial attack of pediatric MS from acute disseminated encephalomyelitis, particularly in very young children. Environmental and genetic factors that appear to increase the risk of pediatric MS include prior infection with Epstein-Barr virus, exposure to cigarette smoke, and HLA-DRB1*15 haplotype. Children may have more posterior fossa involvement at onset and a higher relapse rate than adults with MS. Although time to disability may be longer than in adults, pediatric MS is associated with an earlier age of disability. Off-label use of standard disease-modifying therapies for adult MS is common, although data regarding the efficacy and safety for these medications are limited.",
author = "Mowry, {Ellen Mahar} and Emmanuelle Waubant",
year = "2010",
month = "10",
doi = "10.1212/01.CON.0000389941.99907.c8",
language = "English (US)",
volume = "16",
pages = "181--192",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Pediatric multiple sclerosis

AU - Mowry, Ellen Mahar

AU - Waubant, Emmanuelle

PY - 2010/10

Y1 - 2010/10

N2 - Multiple sclerosis (MS) onset in childhood occurs in a small proportion of individuals with the disease, although the precise incidence of pediatric MS is unknown. It may be difficult to distinguish the initial attack of pediatric MS from acute disseminated encephalomyelitis, particularly in very young children. Environmental and genetic factors that appear to increase the risk of pediatric MS include prior infection with Epstein-Barr virus, exposure to cigarette smoke, and HLA-DRB1*15 haplotype. Children may have more posterior fossa involvement at onset and a higher relapse rate than adults with MS. Although time to disability may be longer than in adults, pediatric MS is associated with an earlier age of disability. Off-label use of standard disease-modifying therapies for adult MS is common, although data regarding the efficacy and safety for these medications are limited.

AB - Multiple sclerosis (MS) onset in childhood occurs in a small proportion of individuals with the disease, although the precise incidence of pediatric MS is unknown. It may be difficult to distinguish the initial attack of pediatric MS from acute disseminated encephalomyelitis, particularly in very young children. Environmental and genetic factors that appear to increase the risk of pediatric MS include prior infection with Epstein-Barr virus, exposure to cigarette smoke, and HLA-DRB1*15 haplotype. Children may have more posterior fossa involvement at onset and a higher relapse rate than adults with MS. Although time to disability may be longer than in adults, pediatric MS is associated with an earlier age of disability. Off-label use of standard disease-modifying therapies for adult MS is common, although data regarding the efficacy and safety for these medications are limited.

UR - http://www.scopus.com/inward/record.url?scp=78650728243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650728243&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000389941.99907.c8

DO - 10.1212/01.CON.0000389941.99907.c8

M3 - Article

VL - 16

SP - 181

EP - 192

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 5

ER -